| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
9,230,000 |
| Market
Cap: |
3.60(M) |
| Last
Volume: |
426,351 |
Avg
Vol: |
425,187 |
| 52
Week Range: |
$0.39 - $0.39 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company working to develop cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin Dependent Kinase 2/9 (CDK2/9) inhibitor, in solid tumors and hematological malignancies. The anti-mitotic program is evaluating CYC140, a Polo-Like-Kinase 1(PLK 1) inhibitor, in cancers. CDKs are a family of enzymes discovered as regulators of the cell cycle. PLK1 is a serine/threonine kinase with a central role in cell division, or the mitotic phase of the cell cycle, and is a regulator of the DNA damage checkpoint.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
7,956 |
7,956 |
7,956 |
| Total Buy Value |
$0 |
$26,374 |
$26,374 |
$26,374 |
| Total People Bought |
0 |
2 |
2 |
2 |
| Total Buy Transactions |
0 |
2 |
2 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Marxe Austin W & Greenhouse David M |
officerTitle |
– – • |
2005-12-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,265,588 |
|
- |
|
| Langecker Peter |
Director |
– • – |
2005-02-04 |
4 |
B |
$1.88 |
$5,628 |
I/I |
3,000 |
5,000 |
2.1 |
- |
|
| Williams Robert Michael |
Director |
– • – |
2004-12-15 |
4 |
GA |
$0.00 |
$0 |
D/D |
1,156 |
45,700 |
|
- |
|
| Langecker Peter |
Director |
– • – |
2004-06-24 |
4 |
B |
$4.25 |
$4,250 |
I/I |
1,000 |
2,000 |
2.1 |
- |
|
| Langecker Peter |
Director |
– • – |
2004-06-22 |
4 |
B |
$4.25 |
$4,250 |
I/I |
1,000 |
1,000 |
2.1 |
- |
|
| Berenson Ronald J |
President & C.E.O. |
• • – |
2004-04-07 |
4 |
OE |
$0.92 |
$25,049 |
D/D |
27,272 |
430,939 |
|
- |
|
| Arch Venture Partners V Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
B |
$8.00 |
$1,500,000 |
I/I |
187,500 |
1,333,934 |
1.5 |
- |
|
| Arch Venture Partners V Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,866,771 |
1,321,434 |
|
- |
|
| Arch Management Partners Ii Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
B |
$8.00 |
$1,500,000 |
I/I |
187,500 |
1,860,824 |
1.5 |
- |
|
| Arch Management Partners Ii Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,866,771 |
1,685,824 |
|
- |
|
| Arch Venture Partners Llc |
10% Owner |
– – • |
2004-03-19 |
4 |
B |
$8.00 |
$1,500,000 |
I/I |
187,500 |
913,784 |
1.5 |
- |
|
| Arch Venture Partners Llc |
10% Owner |
– – • |
2004-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,866,771 |
726,284 |
|
- |
|
| Berenson Ronald J |
President & C.E.O. |
• • – |
2004-03-19 |
4 |
OE |
$5.23 |
$54,998 |
D/D |
10,526 |
403,667 |
|
- |
|
| Wertheimer Stephen |
Director |
– • – |
2004-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
574,363 |
574,363 |
|
- |
|
| Arch V Entrepreneurs Fund Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
B |
$8.00 |
$1,500,000 |
I/I |
187,500 |
2,052,847 |
1.5 |
- |
|
| Arch V Entrepreneurs Fund Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,865,343 |
1,865,343 |
|
- |
|
| Arch V Entrepreneurs Fund Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,428 |
1,428 |
|
- |
|
| Arch Venture Fund V Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
B |
$8.00 |
$400,000 |
I/I |
50,000 |
1,704,763 |
1.5 |
- |
|
| Arch Venture Fund V Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
B |
$8.00 |
$1,100,000 |
D/D |
137,500 |
349,508 |
2.45 |
- |
|
| Arch Venture Fund V Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,654,763 |
1,654,763 |
|
- |
|
| Arch Venture Fund V Lp |
10% Owner |
– – • |
2004-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
212,008 |
212,008 |
|
- |
|
| Curry Robert E |
Director |
– • – |
2004-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
960,964 |
960,964 |
|
- |
|
| Bybee Clinton |
10% Owner |
– – • |
2004-03-19 |
4 |
B |
$8.00 |
$1,500,000 |
I/I |
187,500 |
2,054,271 |
1.5 |
- |
|
| Bybee Clinton |
10% Owner |
– – • |
2004-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,866,771 |
1,866,771 |
|
- |
|
| Nelsen Robert |
Director |
– • • |
2004-03-19 |
4 |
B |
$8.00 |
$1,500,000 |
I/I |
187,500 |
2,054,271 |
2.25 |
- |
|
281 Records found
|
|
Page 10 of 12 |
|
|
